Danaher Co. (NYSE:DHR) Shares Sold by Insight 2811 Inc.

Insight 2811 Inc. trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 9.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,829 shares of the conglomerate’s stock after selling 199 shares during the period. Insight 2811 Inc.’s holdings in Danaher were worth $509,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher in the 2nd quarter valued at $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher in the second quarter valued at about $25,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher during the second quarter worth about $51,000. Financial Connections Group Inc. acquired a new position in shares of Danaher during the 2nd quarter worth about $51,000. Finally, Western Pacific Wealth Management LP purchased a new position in Danaher in the 1st quarter valued at about $55,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

DHR has been the topic of a number of research analyst reports. UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a research note on Thursday, October 31st. Raymond James lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, Stifel Nicolaus increased their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Stock Performance

Shares of DHR stock traded down $3.97 during trading hours on Friday, reaching $235.41. 522,831 shares of the company’s stock were exchanged, compared to its average volume of 2,737,974. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company’s 50 day moving average is $262.91 and its two-hundred day moving average is $260.49. The company has a market cap of $170.03 billion, a P/E ratio of 45.00, a price-to-earnings-growth ratio of 4.44 and a beta of 0.85. Danaher Co. has a 1 year low of $206.30 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.02 earnings per share. Equities research analysts anticipate that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.